Adenine Or Substituted Adenine Patents (Class 536/26.13)
  • Publication number: 20030007961
    Abstract: Orthomolecular Vitamin E derivative compounds, compositions, and their uses for effecting aging and longevity, nerve activity, hematopoiesis and maintenance of blood cells, hepatic activity, nephritic activity, heart and cardiovascular function, pulmonary function, muscular function, cartilage, bone, and joint health, gastrointestinal function, reproductive system function, vision, immune function, cell membrane integrity, and pain and inflammation; preventing or treating diseases or conditions; treating cancers or obesity; and reducing the risk of Sudden Infant Death Syndrome in an animal.
    Type: Application
    Filed: June 22, 2001
    Publication date: January 9, 2003
    Inventor: Michael D. Wilburn
  • Publication number: 20020155478
    Abstract: The present invention relates to isotopically enriched nucleic acids and methods for their production and purification. The invention further relates to methods for the use of said nucleic acids in analysis with mass spectrometry. Use of isotopically enriched nucleic acids in creating second generation products is also provided.
    Type: Application
    Filed: January 18, 2002
    Publication date: October 24, 2002
    Applicant: emerGen, Inc.
    Inventors: Chad C. Nelson, Lesa M. Nelson
  • Patent number: 6420546
    Abstract: The invention relates to oligoribonucleotide analogs with terminal 3′—3′ and/or 5′—5′ internucleotide linkages. This modification stabilizes the molecules altered in this way, including ribozymes, without adversely altering their properties, including, where appropriate, catalytic activities.
    Type: Grant
    Filed: April 14, 1998
    Date of Patent: July 16, 2002
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Heinz Hartmut Seliger, Flavio Ramalho Ortigao, Hannelore Rösch, Rudi Rösch, Bernd Krist
  • Patent number: 6225450
    Abstract: The invention describes a new method to sequence DNA. The improvements over the existing DNA sequencing technologies are high speed, high throughput, no electrophoresis and gel reading artifacts due to the complete absence of an electrophoretic step, and no costly reagents involving various substitutions with stable isotopes. The invention utilizes the Sanger sequencing strategy and assembles the sequence information by analysis of the nested fragments obtained by base-specific chain termination via their different molecular masses using mass spectrometry, as for example, MALDI or ES mass spectrometry. A flirter increase in throughput can be obtained by introducing mass-modifications in the oligonucleotide primer, chain-terminating nucleoside triphosphates and/or in the chain-elongating nucleoside triphosphates, as well as using integrated tag sequences which allow multiplexing by hybridization tag specific probes with mass differentiated molecular weights.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: May 1, 2001
    Assignee: Sequenom, Inc.
    Inventor: Hubert Köster